Saturday, July 11, 2026

pharma · Melanoma

Piramal Critical Care

Piramal Critical Care is a pharma organization headquartered in Voorschoten, NL. Primary therapeutic focus areas include Melanoma. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to

Bethlehem, USA HQ
339 Employees
EMA registrant Type
Company details
Status
Public
HQ
Bethlehem, USA
Employees
339
Programs
1
Drugs
1
Patents
0
Clinical program

P276-00

Phase 2 · small molecule · Melanoma

P276-00 for Melanoma is a Phase 2 program (small_molecule) at Piramal Critical Care B.V. with 1 ClinicalTrials.gov record(s).

← All Piramal Critical Care B.V. projects Phase 2 small molecule completed

Internal code P276-00/27/08

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Piramal Critical Care B.V.
Phase
Phase 2
Modality
small_molecule
Indication
Melanoma
Status
completed
Trials
1